CureVac Stock Could Fall Even Further After Vaccine News – Barrons

Wall Street analysts are taking a far more pessimistic view of CureVac as the stock tumbles after the German biotech reported disappointing results from a late-stage trial of a Covid-19 vaccine on We… [+249 chars]